Pituitary carcinoma: Difficult diagnosis and treatment

Journal of Clinical Endocrinology and Metabolism

Volumn 96, Issue 12, 2011, Pages 3649-3660

  Heaney, Anthony P ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; CARMOFUR; CISPLATIN; CYCLINE; CYCLOPHOSPHAMIDE; DNA METHYLTRANSFERASE; DNA POLYMERASE; DOXORUBICIN; ETOPOSIDE; FLUOROURACIL; FOLINIC ACID; LOMUSTINE; METHOTREXATE; MITOTANE; PASIREOTIDE; PROCARBAZINE; PROLACTIN; TAMOXIFEN; TEMOZOLOMIDE; VINBLASTINE;

ACROMEGALY; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CELL PROLIFERATION; CORTICOTROPH PITUITARY CARCINOMA; DRUG EFFICACY; EARLY DIAGNOSIS; ENDOCRINE FUNCTION; ENDOCRINE TUMOR; EXTERNAL BEAM RADIOTHERAPY; GONADOTROPH CARCINOMA; GROWTH HORMONE SECRETING CARCINOMA; HISTOPATHOLOGY; HORMONE RESPONSE; HUMAN; IMMUNOHISTOCHEMISTRY; INCIDENCE; MOLECULAR DYNAMICS; MULTIPLE CYCLE TREATMENT; PITUITARY CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SEX DIFFERENCE; STEREOTAXIC SURGERY; SURVIVAL RATE; SYSTEMATIC REVIEW; THYROTROPH CARCINOMA; TREATMENT RESPONSE; CARCINOMA; HYPOPHYSIS TUMOR; PROGNOSIS;

CARCINOMA; HUMANS; PITUITARY NEOPLASMS; PROGNOSIS;

EID: 83155175577     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2011-2031     Document Type: Review

References (85)

1. Amar AP, Hinton DR, Krieger MD, Weiss MH 1999 Invasive pituitary adenomas: significance of proliferation parameters. Pituitary 2:117-122
2. Thapar K, Kovacs K, Scheithauer BW, Stefaneanu L, Horvath E, Pernicone PJ, Murray D, Laws Jr ER 1996 Proliferative activity and invasiveness among pituitary adenomas and carcinomas: an analysis using the MIB-1 antibody. Neurosurgery 38:99-106; discussion 106-107
3. Scheithauer BW, Kovacs KT, Laws Jr ER, Randall RV 1986 Pathology of invasive pituitary tumors with special reference to functional classification. J Neurosurg 65:733-744 (Pubitemid 17187407)
4. Daly AF, Tichomirowa MA, Beckers A 2009 The epidemiology and genetics of pituitary adenomas. Best Pract Res Clin Endocrinol Metab 23:543-554
5. Roncaroli F, Scheithauer BW, Horvath E, Erickson D, Tam CK, Lloyd RV, Kovacs K 2010 Silent subtype 3 carcinoma of the pituitary: a case report. Neuropathol Appl Neurobiol 36:90-94
6. Kontogeorgos G 2005 Classification and pathology of pituitary tumors. Endocrine 28:27-35 (Pubitemid 43004798)
7. Pernicone PJ, Scheithauer BW, Sebo TJ, Kovacs KT, Horvath E, Young Jr WF, Lloyd RV, Davis DH, Guthrie BL, Schoene WC 1997 Pituitary carcinoma: a clinicopathologic study of 15 cases. Cancer 79:804-812 (Pubitemid 27076347)
8. Cusimano MD, Ohori P, Martinez AJ, Jungreis C, Wright DC 1994 Pituitary carcinoma. Skull Base Surgery 4:46-51 (Pubitemid 24060996)
9. Kaltsas GA, Grossman AB 1998 Malignant pituitary tumors. Pituitary 1:69-81
10. Scheithauer BW, Fereidooni F, Horvath E, Kovacs K, Robbins P, Tews D, Henry K, Pernicone P, Gaffrey Jr TA, Meyer FB, Young Jr WF, Fahlbusch R, Buchfelder M, Lloyd RV 2001 Pituitary carcinoma: an ultrastructural study of eleven cases. Ultrastruct Pathol 25:227-242 (Pubitemid 32607296)
11. Brown RL, Muzzafar T, Wollman R, Weiss RE 2006 A pituitary carcinoma secreting TSH and prolactin: a non-secreting adenoma gone awry. Eur J Endocrinol 154:639-643 (Pubitemid 43810848)
12. Stefaneanu L, Kovacs K, Horvath E, Lloyd RV, Buchfelder M, Fahlbusch R, Smyth H 1994 In situ hybridization study of estrogen receptor messenger ribonucleic acid in human adenohypophysial cells and pituitary adenomas. J Clin Endocrinol Metab 78:83-88 (Pubitemid 24026752)
13. Lv H, Li C, Gui S, Zhang Y 21 March 2011 Expression of estrogen receptor alpha and growth factors in human prolactinoma and its correlation with clinical features and gender. J Endocrinol Invest 10.3275/7607
14. Branch Jr CL, Laws Jr ER 1987 Metastatic tumors of the sella turcica masquerading as primary pituitary tumors. J Clin Endocrinol Metab 65:469-474 (Pubitemid 17135167)
15. Morita A, Meyer FB, Laws Jr ER 1998 Symptomatic pituitary metastases. J Neurosurg 89:69-73 (Pubitemid 28285924)
16. Mountcastle RB, Roof BS, Mayfield RK, Mordes DB, Sagel J, Biggs PJ, Rawe SE 1989 Pituitary adenocarcinoma in an acromegalic patient: response to bromocriptine and pituitary testing: a review of the literature on 36 cases of pituitary carcinoma. Am J Med Sci 298:109-118 (Pubitemid 19195573)
17. Gillam MP, Middler S, Freed DJ, Molitch ME 2002 The novel use of very high doses of cabergoline and a combination of testosterone and an aromatase inhibitor in the treatment of a giant prolactinoma. J Clin Endocrinol Metab 87:4447-4451 (Pubitemid 35247022)
18. Lim JS, Ku CR, Lee MK, Kim TS, Kim SH, Lee EJ 2010 A case of fugitive acromegaly, initially presenting as invasive prolactinoma. Endocrine 38:1-5
19. Lim S, Shahinian H, Maya MM, Yong W, Heaney AP 2006 Temozolomide: a novel treatment for pituitary carcinoma. Lancet Oncol 7:518-520 (Pubitemid 43796152)
20. Sheldon WH, Golden A, Bondy PK 1954 Cushing's syndrome produced by a pituitary basophil carcinoma with hepatic metastases. Am J Med 17:134-142
21. McCutcheon IE, Pieper DR, Fuller GN, Benjamin RS, Friend KE, Gagel RF 2000 Pituitary carcinoma containing gonadotropins: treatment by radical excision and chemotherapy: case report. Neurosurgery 46:1233-1239; discussion 1239-1240; discussion 1239-1240
22. Roncaroli F, Nosé V, Scheithauer BW, Kovacs K, Horvath E, Young Jr WF, Lloyd RV, Bishop MC, Hsi B, Fletcher JA 2003 Gonadotropic pituitary carcinoma: HER-2/neu expression and gene amplification - report of two cases. J Neurosurg 99:402-408 (Pubitemid 36900136)
23. Beauchesne P, Trouillas J, Barral F, Brunon J 1995 Gonadotropic pituitary carcinoma: case report. Neurosurgery 37:810-816
24. Spertini F, Deruaz JP, Perentes E, Pelet B, Gomez F 1986 Luteinizing hormone (LH) and prolactin-secreting pituitary tumor: possible malignant transformation of the LH cell line. J Clin Endocrinol Metab 62:849-854 (Pubitemid 16106707)
25. Mixson AJ, Friedman TC, Katz DA, Feuerstein IM, Taubenberger JK, Colandrea JM, Doppman JL, Oldfield EH, Weintraub BD 1993 Thyrotropin-secreting pituitary carcinoma. J Clin Endocrinol Metab 76:529-533 (Pubitemid 23073087)
26. Heaney AP, Melmed S 2004 Pituitary tumors: molecular targets and new medical therapies. Nat Rev Cancer 4:285-295 (Pubitemid 38525284)
27. Theodoropoulou M, Cavallari I, Barzon L, D'Agostino DM, Ferro T, Arzberger T, Grübler Y, Schaaf L, Losa M, Fallo F, Ciminale V, Stalla GK, Pagotto U 2004 Differential expression of menin in sporadic pituitary adenomas. Endocr Relat Cancer 11:333-344 (Pubitemid 38832834)
28. Pei L, Melmed S, Scheithauer B, Kovacs K, Prager D 1994 H-ras mutations in human pituitary carcinoma metastasis. J Clin Endocrinol Metab 78:842-846 (Pubitemid 24118075)
29. Thapar K, Kovacs K, Muller PJ 1995 Clinical-pathologic Correlations of Pituitary Tumors. Baillieres Clin Endocrinol Metab 9:243-270
30. Challa VR, Marshall RB, Hopkins 3rd MB, Kelly Jr DL, Civantos F 1985 Pathobiologic study of pituitary tumors: report of 62 cases with a review of the recent literature. Hum Pathol 16:873-884 (Pubitemid 15238269)
31. Saeger W, Lüdecke DK, Buchfelder M, Fahlbusch R, Quabbe HJ, Petersenn S 2007 Pathohistological classification of pituitary tumors: 10 years of experience with the German Pituitary Tumor Registry. Eur J Endocrinol 156:203-216 (Pubitemid 46554515)
32. Hashimoto N, Handa H, Nishi S 1986 Intracranial and intraspinal dissemination from a growth hormone-secreting pituitary tumor. J Neurosurg 64:140-144 (Pubitemid 16189612)
33. Kovacs K 2006 The 2004 WHO classification of pituitary tumors: comments. Acta Neuropathol 111:62-63
34. Salehi F, Agur A, Scheithauer BW, Kovacs K, Lloyd RV, Cusimano M 2009 Ki-67 in pituitary neoplasms: a review - Part I. Neurosurgery 65:429-437
35. Scheithauer BW, Gaffey TA, Lloyd RV, Sebo TJ, Kovacs KT, Horvath E, Yapicier O, Young Jr WF, Meyer FB, Kuroki T, Riehle DL, Laws Jr ER 2006 Pathobiology of pituitary adenomas and carcinomas. Neurosurgery 59:341-353 (Pubitemid 44325877)
36. Tanizaki Y, Jin L, Scheithauer BW, Kovacs K, Roncaroli F, Lloyd RV 2007 p53 Gene mutations in pituitary carcinomas. Endocr Pathol 18:217-222
37. Thapar K, Scheithauer BW, Kovacs K, Pernicone PJ, Laws Jr ER 1996 p53 Expression in pituitary adenomas and carcinomas: correlation with invasiveness and tumor growth fractions. Neurosurgery 38:765-770; discussion 770-771
38. Scheithauer BW, Kurtkaya-Yapicier O, Kovacs KT, Young Jr WF, Lloyd RV 2005 Pituitary carcinoma: a clinicopathological review. Neurosurgery 56:1066-1074 (Pubitemid 40628116)
39. Manahan MA, Dackiw AP, Ball DW, Zeiger MA 2007 Unusual case of metastatic neuroendocrine tumor. Endocr Pract 13:72-76
40. Ragel BT, Couldwell WT 2004 Pituitary carcinoma: a review of the literature. Neurosurg Focus 16:E7
41. Lopes MB, Scheithauer BW, Schiff D 2005 Pituitary carcinoma: diagnosis and treatment. Endocrine 28:115-121 (Pubitemid 43004809)
42. Saeger W, Lubke D 1996 Pituitary carcinomas. Endocr Pathol 7:21-35 (Pubitemid 126717324)
43. Garrão AF, Sobrinho LG, Pedro-Oliveira, Bugalho MJ, Boavida JM, Raposo JF, Loureiro M, Limbert E, Costa I, Antunes JL 1997 ACTH-producing carcinoma of the pituitary with haematogenic metastases. Eur J Endocrinol 137:176-180
44. Frost AR, Tenner S, Tenner M, Rollhauser C, Tabbara SO 1995 ACTH-producing pituitary carcinoma presenting as the cauda equina syndrome. Arch Pathol Lab Med 119:93-96
45. Ayuk J, Natarajan G, Geh JI, Mitchell RD, Gittoes NJ 2005 Pituitary carcinoma with a single metastasis causing cervical spinal cord compression: case report. J Neurosurg Spine 2:349-353
46. Cartwright DM, Miller TR, Nasr AJ 1994 Fine-needle aspiration biopsy of pituitary carcinoma with cervical lymph node metastases: a report of two cases and review of the literature. Diagn Cytopathol 11:68-73 (Pubitemid 24258816)
47. Kaltsas GA, Mukherjee JJ, Plowman PN, Monson JP, Grossman AB, Besser GM 1998 The role of cytotoxis chemotherapy in the management of aggressive and malignant pituitary tumors. J Clin Endocrinol Metab 83:4233-4238 (Pubitemid 29100114)
48. Swords FM, Allan CA, Plowman PN, Sibtain A, Evanson J, Chew SL, Grossman AB, Besser GM, Monson JP 2003 Stereotactic radiosurgery XVI: a treatment for previously irradiated pituitary adenomas. J Clin Endocrinol Metab 88:5334-5340 (Pubitemid 37452736)
49. Loeffler JS, Shih HA 2011 Radiation therapy in the management of pituitary adenomas. J Clin Endocrinol Metab 96:1992-2003
50. Rowland NC, Aghi MK 2010 Radiation treatment strategies for acromegaly. Neurosurg Focus 29:E12
51. Sheehan JP, Pouratian N, Steiner L, Laws ER, Vance ML 2011 Gamma knife surgery for pituitary adenomas: factors related to radiological and endocrine outcomes. J Neurosurg 114:303-309
52. Castinetti F, Nagai M, Dufour H, Kuhn JM, Morange I, Jaquet P, Conte-Devolx B, Regis J, Brue T 2007 Gamma knife radiosurgery is a successful adjunctive treatment in Cushing's disease. Eur J Endocrinol 156:91-98 (Pubitemid 46553907)
53. Kwekkeboom DJ, de Herder WW, Krenning EP 2011 Somatostatin receptor-targeted radionuclide therapy in patients with gastroenteropancreatic neuroendocrine tumors. Endocrinol Metab Clin North Am 40:173-185, ix
54. Walker JD, Grossman A, Anderson JV, Ur E, Trainer PJ, Benn J, Lowy C, Sönksen PH, Plowman PN, Lowe DG, 1993 Malignant prolactinoma with extracranial metastases: a report of three cases. Clin Endocrinol (Oxf) 38:411-419 (Pubitemid 23105075)
55. Melmed S, Sternberg R, Cook D, Klibanski A, Chanson P, Bonert V, Vance ML, Rhew D, Kleinberg D, Barkan A 2005 A critical analysis of pituitary tumor shrinkage during primary medical therapy in acromegaly. J Clin Endocrinol Metab 90:4405-4410 (Pubitemid 41058228)
56. Biller BM, Grossman AB, Stewart PM, Melmed S, Bertagna X, Bertherat J, Buchfelder M, Colao A, Hermus AR, Hofland LJ, Klibanski A, Lacroix A, Lindsay JR, Newell-Price J, Nieman LK, Petersenn S, Sonino N, Stalla GK, Swearingen B, Vance ML, Wass JA, Boscaro M 2011 Pasireotide (SOM230) demonstrates efficacy in patients with Cushing disease: results from a larger randomized-dose, double-blind, phase III study. Endocr Rev 32;OR09-6 (Abstract)
57. Bode H, Seiz M, Lammert A, Brockmann MA, Back W, Hammes HP, Thomé C 2010 SOM230 (pasireotide) and temozolomide achieve sustained control of tumour progression and ACTH secretion in pituitary carcinoma with widespread metastases. Exp Clin Endocrinol Diabetes 118:760-763
58. Fadul CE, Kominsky AL, Meyer LP, Kingman LS, Kinlaw WB, Rhodes CH, Eskey CJ, Simmons NE 2006 Long-term response to pituitary carcinoma to temozolomide: report of two cases. J Neurosurg 105:621-626 (Pubitemid 44525896)
59. Komninos J, Vlassopoulou V, Protopapa D, Korfias S, Kontogeorgos G, Sakas DE, Thalassinos NC 2004 Tumors metastatic to the pituitary gland: case report and literature review. J Clin Endocrinol Metab 89:574-580 (Pubitemid 38269860)
60. Esteller M, Garcia-Foncillas J, Andion E, Goodman SN, Hidalgo OF, Vanaclocha V, Baylin SB, Herman JG 2000 Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents. N Engl J Med 343:1350-1354
61. 6-methylguanine-DNA methyltransferase (MGMT) expression and response to temozolomide in aggressive pituitary tumors. Clin Endocrinol (Oxf) 71:226-233
62. Hagen C, Schroeder HD, Hansen S, Hagen C, Andersen M 2009 Temozolomide treatment if a pituitary carcinoma and two pituitary macroadenomas resistant to conventional therapy. Eur J Endocrinol 161:631-637
63. Kovacs K, Horvath E, Syro LV, Uribe H, Penagos LC, Ortiz LD, Fadul CE 2007 Temozolomide therapy in a man with an aggressive prolactin-secreting pituitary neoplasm: morphological findings. Hum Pathol 38:185-189 (Pubitemid 44880216)
64. Kovacs K, Scheithauer BW, Lombardero M, McLendon RE, Syro LV, Uribe H, Ortiz LD, Penagos LC 2008 MGMT immunoexpression predicts responsiveness of pituitary tumors to temozolomide therapy. Acta Neuropathol 115:261-262
65. Raverot G, Sturm N, de Fraipont F, Muller M, Salenave S, Caron P, Chabre O, Chanson P, Cortet-Rudelli C, Assaker R, Dufour H, Gaillard S, François P, Jouanneau E, Passagia JG, Bernier M, Cornélius A, Figarella-Branger D, Trouillas J, Borson-Chazot F, Brue T 2010 Temozolomide treatment of aggressive pituitary tumors and pituitary carcinomas: a French multicenter experience. J Clin Endocrinol Metab 95:4592-4599
66. Kaiser FE, Orth DN, Mukai K, Oppenheimer JH 1983 A pituitary parasellar tumor with extracranial metastases and high, partially suppressible levels of adrenocorticotropin and related peptides. J Clin Endocrinol Metab 57:649-653 (Pubitemid 13005537)
67. Asai A, Matsutani M, Funada N, Takakura K 1988 Malignant growth hormone-secreting pituitary adenoma with haematogenous dural metastasis: case report. Neurosurgery 22:1091-1094
68. Nawata H, Higuchi K, Ikuyama S, Kato K, Ibayashi H, Mimura K, Sueishi K, Zingami H, Imura H 1990 Corticotropin-releasing hormone- and adrenocorticotropin-producing pituitary carcinoma with metastases to the liver and lung in a patient with Cushing's disease. J Clin Endocrinol Metab 71:1068-1073
69. Petterson T, MacFarlane IA, MacKenzie JM, Shaw MDM 1992 Prolactin secreting pituitary carcinoma. J Neurol Neurosurg Psychiatry 55:1205-1206 (Pubitemid 23010105)
70. Gollard R, Kosty M, Cheney C, Copeland B, Bordin G 1995 Prolactin-secreting pituitary carcinoma with implants in the cheek pouch and metastases to the ovaries. Cancer 76:1814-1820
71. Hurel SJ, Harris PE, McNicol AM, Foster S, Kelly WF, Baylis PH 1997 Metastatic prolactinoma: effect of octreotide, cabergoline, carboplatin and etoposide; immunocytochemical analysis of protooncogene expression. J Clin Endocrinol Metab 82:2962-2965 (Pubitemid 27385656)
72. Moyes VJ, Alusi G, Sabin HI, Evanson J, Berney DM, Kovacs K, Monson JP, Plowman PN, Drake WM 2009 Treatment of Nelson's syndrome with temozolomide. Eur J Endocrinol 160:115-119
73. Raverot G, Wierinckx A, Dantony E, Auger C, Chapas G, Villeneuve L, Brue T, Figarella-Branger D, Roy P, Jouanneau E, Jan M, Lachuer J, Trouillas J 2010 Prognostic factors in prolactin pituitary tumors: clinical, histological, and molecular data from a series of 94 patients with a long postoperative follow-up. J Clin Endocrinol Metab 95:1708-1716
74. Moin T, Yong WH, Heaney AP 2011 Atypical adenoma, pituitary carcinoma and the role of chemotherapy in the management of refractory pituitary adenoma. In: Schwartz TH, Anand VK, eds. Endoscopic pituitary surgery. New York: Thieme Publishers
75. Bush ZM, Longtine JA, Cunningham T, Schiff D, Jane Jr JA, Vance ML, Thorner MO, Laws Jr ER, Lopes MB 2010 Temozolomide treatment for aggressive pituitary tumors: correlation of clinical outcomes with DNA methylation and MGMT expression. J Clin Endocrinol Metab 95:E280-E290
76. Murakami M, Mizutani A, Asano S, Katakami H, Ozawa Y, Yamazaki K, Ishida Y, Takano K, Okinaga H, Matsuno A 2011 A mechanism of acquiring temozolomide resistance during transformation of atypical prolactinoma into prolactin-producing pituitary carcinoma: case report. Neurosurgery 68:E1761-E1767; discussion E1767
77. Greenman Y, Woolf P, Coniglio J, O'Mara R, Pei L, Said JW, Melmed S 1996 Remission of acromegaly caused by pituitary carcinoma after surgical excision of growth hormone-secreting metastasis detected by 111-indium pentetreotide scan. J Clin Endocrinol Metab 81:1628-1633 (Pubitemid 26118604)
78. Ahmed M, Kanaan I, Alarifi A, Ba-Essa E, Saleem M, Tulbah A, McArthur P, Hessler R 2000 ACTH-producing pituitary cancer: experience at the King Faisal Specialist Hospital, Research Center. Pituitary 3:105-112 (Pubitemid 32798988)
79. Pivot X, Bedairia N, Thiery-Vuillemin A, Espie M, Marty M 2011 Combining molecular targeted therapies: clinical experience. Anticancer Drugs 22:701-710
80. Raymond E, Dahan L, Raoul JL, Bang YJ, Borbath I, Lombard-Bohas C, Valle J, Metrakos P, Smith D, Vinik A, Chen JS, Hörsch D, Hammel P, Wiedenmann B, Van Cutsem E, Patyna S, Lu DR, Blanckmeister C, Chao R, Ruszniewski P 2011 Sunitinib malate for the treatment of pancreatic neuroendocrine tumors. N Engl J Med 364:501-513
81. Yao JC, Shah MH, Ito T, Bohas CL, Wolin EM, Van Cutsem E, Hobday TJ, Okusaka T, Capdevila J, de Vries EG, Tomassetti P, Pavel ME, Hoosen S, Haas T, Lincy J, Lebwohl D, Öberg K 2011 Everolimus for advanced pancreatic neuroendocrine tumors. N Engl J Med 364:514-523
82. Zatelli MC, Minoia M, Filieri C, Tagliati F, Buratto M, Ambrosio MR, Lapparelli M, Scanarini M, Degli Uberti EC 2010 Effect of everolimus on cell viability in nonfunctioning pituitary adenomas. J Clin Endocrinol Metab 95:968-976
83. Kulke MH, Siu LL, Tepper JE, Fisher G, Jaffe D, Haller DG, Ellis LM, Benedetti JK, Bergsland EK, Hobday TJ, Van Cutsem E, Pingpank J, Oberg K, Cohen SJ, Posner MC, Yao JC 2011 Future directions in the treatment of neuroendocrine tumors: consensus report of the National Cancer Institute neuroendocrine tumor clinical trials planning meeting. J Clin Oncol 29:934-943
84. Wander SA, Hennessy BT, Slingerland JM 2011 Next-generation mTOR inhibitors in clinical oncology: how pathway complexity informs therapeutic strategy. J Clin Invest 121:1231-1241
85. Perez CA, Santos ES, Arango BA, Raez LE, Cohen EE 4 May 2011 Novel molecular targeted therapies for refractory thyroid cancer. Head Neck 10.1002/hed.21755